We believe we can uniquely help connect the teams, data and decisions in every step from discovery to diagnosis to treatment with innovations that will ultimately help you deliver intelligently efficient, precise, personalized care. There is so much data available across molecular imaging today. There are so many connection opportunities and loops to close. That's where we see significant opportunity. And we believe we're in a unique position to fulfill this vision because we are the only partner with pharmaceutical diagnostics, cyclotrons, chemistry synthesis, PET/CT, PET/MR, nuclear medicine, advanced digital solutions and pharma partnerships to cover the breadth of steps from discovery to treatment.

See how advanced monitoring solutions can help evaluate a chosen treatment path to elevate care team collaboration with new insight into treatment progression.

• Nuclear Medicine
• Advanced applications
• AI-powered applications

Featured product
StarGuide
StarGuide™, our most advanced SPECT/CT, helps providers seeking pathways toward effective treatments that have yet to be explored. It provides many technologies and productivity tools to help physicians lead the way toward effective medical care while maintaining the ability to deliver efficient imaging solutions within demanding clinical environments.

PET/CT is made for personalized care. High resolution and exceptional sensitivity allow it to detect small lesions, and quantitative tools make it possible to more accurately monitor therapy. It reaches beyond oncology with disease-specific tracers for neurology and cardiology. Our goal is to help deliver on the promise of personalized care by helping you see more, see smaller, see clearly and see changes.

Nuclear medicine is an excellent choice for physicians at the forefront of medicine. With a wide range of available isotopes and the flexibility to explore multiple pathways in a single session, these instruments are full of potential. Our latest advancements are making nuclear medicine technology more accessible and enabling it to provide you with more meaningful clinical answers.

"In general, I think that quantitation is one of the
most important factors in the growth of therapy in
nuclear medicine."

Dr. Serena Grimaldi

A complete PET imaging solution requires accessible and reliable PET tracer production. Our PET Radiopharmacy portfolio includes a wide array of PET tracer production technologies, delivering the only complete PET solution in the industry. All designed to help you get your PET department up and running right away.

Our MI Digital Solutions are designed to give you the freedom to control your workflow and collaborate with your peers. It starts with securing all of your molecular imaging data in the cloud. Then you can streamline your workflow with AI-powered clinical applications.

Smart Subscription is the industry’s first subscription-based service for MI applications. With Smart Subscription, all of your MI devices are continually updated with the latest applications. Instead of technology that starts to “fall behind” from the time you order it, you get a device that can always provide the latest capabilities.

1. Radiopharmaceuticals may not be approved by ministers of health in all regions.
2. Source: Global Cancer Statistics 2020: https://doi.org/10.3322/caac.21660